Russia to start Phase III preliminaries of second COVID-19 antibody in November-December: Report Kumar Jeetendra | October 2, 2020 Russia begins Phase III trials of a second possible vaccine against COVID-19, developed by Siberia’s Vector Institute, in November-December, the TASS news agency cited Russian consumer security watchdog Rospotrebnadzor as saying on October 2. Early-stage clinical trials for the vaccine have been completed on Wednesday.
Moderna antibody preliminary temporary workers neglect to select enough minorities, inciting lull Kumar Jeetendra | October 6, 2020 Private contractors hired by Moderna Inc to recruit volunteers for its coronavirus vaccine trial failed to enrol enough Black, Latino and Native American participants to ascertain how well the vaccine works in such populations, company executives and vaccine researchers told Reuters. To compensate for the shortfall, Moderna slowed registration of its late-stage trial and educated …
Indo-Israel fast COVID-19 testing examination to fructify in ‘matter of days’: Israeli agent Kumar Jeetendra | October 9, 2020 A game-changer rapid COVID-19 testing technologies being jointly developed by India and Israel should be prepared for rollout in”a matter of days” and it’ll have the ability to give test results in less than a minute by simply requiring an individual to blow into a tube, the Israeli envoy to India has stated. Ambassador Ron …
High-dosage favipiravir ‘strong’ against COVID-19, HCQ totally incapable: Study Kumar Jeetendra | October 11, 2020 Research conducted at the KU Leuven Rega Institute in Belgium has found that the antimalarial drug hydroxychloroquine (HCQ) doesn’t limit the multiplication of the novel coronavirus. However, a very high dose of the flu drug favipiravir does have antiviral efficacy, according to their results. The researchers gave the hamsters either hydroxychloroquine or favipiravir for four …
Johnson and Johnson stops preliminaries because of unexplained ailment in member Kumar Jeetendra | October 13, 2020 Johnson & Johnson said on October 12 it has temporarily paused clinical trials of its own COVID-19 vaccine candidate because of an unexplained illness in a research participant. In a statement, the company said that the participant’s illness has been reviewed and assessed by an independent data and safety monitoring board, and its clinical and …
Eli Lilly delays preliminary of antibody drug Donald Trump promoted as COVID-19 ‘cure’ over wellbeing concern Kumar Jeetendra | October 14, 2020 Eli Lilly and Co said on Tuesday the clinical trial of its COVID-19 antibody treatment similar to one taken by US President Donald Trump has been paused due to a safety concern. Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as compared to …
Handwashing a compelling device to forestall COVID-19, different ailments: WHO Kumar Jeetendra | October 15, 2020 Ten weeks into the pandemic, handwashing with soap and other public health measures like maintaining physical distance, practising cough etiquette and wearing a mask stay the best defence against coronavirus, the World Health Organisation said Global Handwashing Day is observed on October 15 each year to increase awareness and emphasize the importance of handwashing as …
Chinese COVID-19 immunization competitor shows guarantee in human preliminary: Study Kumar Jeetendra | October 16, 2020 One of China’s leading COVID-19 vaccine candidates, called BBIBP-CorV, was proven to be safe and elicited immune response in a small early-phase human trial, researchers said on Friday. A previous clinical trial reported similar results for a different vaccine that’s also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only …
Britain draws nearer to COVID-19 immunization preliminaries that contaminate volunteers Kumar Jeetendra | October 16, 2020 “Human challenge” trials of possible COVID-19 vaccines, where volunteers are deliberately infected with the disease, could become a reality after a British biotech firm signed a contract with the government to create and provide strains of this virus. Preliminary work for the trials, which aim to accelerate the process of determining the efficacy of a …
DRL gets DCGI s gesture to direct COVID-19 immunization stage 2/3 human preliminaries Kumar Jeetendra | October 17, 2020 Dr.Reddys Laboratories Ltd. and Russian Direct Investment Fund, Russias autonomous wealth fund, on Saturday announced they have received approval from the Drug Control General of India to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India. The city-based drug maker said in a press release that this will be a …
Russia gets reestablished endorsement for COVID-19 immunization preliminaries in India: RDIF Kumar Jeetendra | October 17, 2020 The Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the autonomous wealth fund said on Saturday. Large-scale trials of the Sputnik V vaccine in India were announced and then knocked back by Indian regulators, who said the …
Expectation of COVID-19 immunization arrangement in UK by New Year: Report Kumar Jeetendra | October 18, 2020 One of the UK’s senior-most medical chiefs has indicated that a vaccine against COVID-19 could be ready to be deployed by the start of the New Year, according to a media report on Sunday. In India, the vaccine has a Serum Institute of India tie-up since it undergoes trials. “We are not light years away …
